SCHEMBL20437301

SCHEMBL20437301

CC(C)(C)OC(=O)N1CC=C(c2cc3c(cnn3PI)cc2[N+](=O)[O-])CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK4 Q16654 1/20 0.42
JAK1 P23458 1/20 0.41
HTR6 P50406 1/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39
GABRG3 Q99928 1/20 0.39
GABRQ Q9UN88 1/20 0.39
CYP11B2 P19099 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20437476 0.87 PDK4 (0.45) PDK4JAK1HTR6GABRPGABRD
SCHEMBL22873680 0.86 TNF (0.48) PDK4JAK1HTR6GABRPGABRD
SCHEMBL21796772 0.80 JAK1 (0.42) PDK4JAK1HTR6CYP11B2GPR119
SCHEMBL13671245 0.75 PDK4 (0.48) PDK4JAK1HTR6GABRPGABRD
SCHEMBL15771353 0.74 GRM1 (0.52) PDK4JAK1HTR6GRM1GRM5
SCHEMBL30309943 0.74 GRM1 (0.52) PDK4JAK1HTR6GRM1GRM5
SCHEMBL16100540 0.74 NR1H2 (0.52) PDK4JAK1HTR6GABRPGABRD
SCHEMBL30567480 0.74 NR1H2 (0.52) PDK4JAK1HTR6GABRPGABRD
SCHEMBL30567483 0.74 NR1H2 (0.52) PDK4JAK1HTR6GABRPGABRD
SCHEMBL15556671 0.74 PDK4 (0.51) PDK4JAK1HTR6GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018137593-A1 COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-08-02 WO disclosed